drugset / Trial / NCT03598309
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
Phase 2
Active not recruiting
19 enrolled
H. Lee Moffitt Cancer Center and Research Institute
James and Esther King Biomedical Research Program · collab
RandomizedParallel-groupSingle-blindPrevention
Summary
The purpose of this study is to find out if an investigational combination drug called Lovaza (made with fish oils)+Curcumin C3 Complex (made from a root called curcumin) can help reduce the size of lung nodules. Researchers also want to find out if the combination of Lovaza+Curcumin C3 Complex is safe and tolerable.
Timeline
- Start
- 2019-06-05
- Primary completion
- 2025-05-29
- Completion
- 2026-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Curcuminoids | Traditional medicine (herbal / TCM) | 4 g | Oral |
| Comparator | Curcuminoids | Traditional medicine (herbal / TCM) | 8 g | Oral |
| Comparator | Lovaza | Other / unclassified | 2 g | Oral |
| Comparator | Lovaza | Other / unclassified | 4 g | Oral |